This masterclass examines these interactions from puberty through to post-menopause, providing a practical and evidence-based framework for understanding how hormonal transitions can influence both ADHD presentation and treatment outcomes.

 

While menopause and perimenopause form an important part of the programme, the course takes a lifespan approach, exploring key stages including: puberty and menarche, the menstrual cycle, pregnancy, postpartum, perimenopause, menopause and post-menopausal health.

​

The day combines evidence-based teaching with real-world clinical expertise, covering:

• How ADHD presents differently in women and girls, including masking, late diagnosis and gender-related diagnostic bias

• The role of oestrogen and other hormones in brain function, neuroplasticity and mental health

• The impact of hormonal changes on ADHD symptoms and treatment response

• Contemporary prescribing approaches for women with ADHD across different hormonal stages

• ADHD medication considerations during the menstrual cycle, pregnancy, breastfeeding and menopause

• Best-practice menopause management, including the role of HRT and its implications for ADHD treatment

• Common prescribing challenges and medication optimisation strategies in women with ADHD

• ADHD in pregnancy and breastfeeding from a perinatal psychiatry perspective

• Emerging areas including AuDHD, common co-occurring medical conditions and the role of psychological and lifestyle interventions alongside medication

​

A key feature of the masterclass is the inclusion of interactive breakout sessions, providing participants with the opportunity to engage directly with expert faculty in small-group discussions. These sessions are designed to support reflective learning and allow clinicians to explore real-life prescribing dilemmas, treatment challenges and complex cases from their own practice within a supportive, expert-led environment.

 

The programme concludes with a panel discussion exploring how clinical services can evolve to better support women with ADHD throughout different stages of life.

​​​

Who is this course for?

This masterclass is particularly relevant for:

• Psychiatrists

• GPs, especially those with a special interest in ADHD

• Nurse prescribers

• Pharmacists

• Advanced clinical practitioners

• Other clinicians involved in medication management and monitoring

 

It will also be valuable for psychologists, therapists, coaches and allied health professionals who wish to explore an in-depth understanding of ADHD medication, hormonal influences and the wider medical considerations affecting women with ADHD.

 

This course is also suitable in non-clinicians with a significant interest in ADHD in women.

​

This session counts towards 6 CPD hours. Certificates of completion will be provided following the course upon request.

 

This course provides educational information only and does not qualify participants to diagnose or prescribe for ADHD.